Invasive meningococcal disease cases already surpassing 2021 total figures

GSK Australia

Invasive Meningococcal Disease (IMD) cases are on the rise in Australia, as shown in the National Notifiable Diseases Surveillance System’s data, with the total number of cases to the end of September 2022 (86 cases) exceeding last year’s total (74 cases).¹

IMD is a rare bacterial infection, which can progress rapidly. Most people survive IMD, however, if it is not treated quickly, it may cause serious disability or loss of life within 24 hours.^2,3

Up to 1 in 10 people infected with IMD may die, and up to 1 in 5 survivors may develop serious long-term complications, including brain damage, deafness or loss of limbs.³

Babies (less than 2 years of age), and adolescents (15–19 years of age) are most vulnerable to the disease.⁴

Early signs and symptoms may be difficult to diagnose as they can easily be mistaken for a common cold, for example high fever or lethargy.²

/Public Release.

IATA Disappointed with New US DOT Consumer Protection Rules

Record High Mad March Tees Up Awesome April

Pakistan and Bangladesh Blocking Over $720m of Airline Revenues

Tail Rotor Collision During Marine Pilot Transfer

AMSA Annual Inspections Report provides safety snapshot of domestic and international vessels in Australia

Motorcyclists On Our Roads: How To Share Road Safely

Skippers Need To Undertake Checks Prior To Departure

Flight Below Glideslope At Sydney